Key result
Combined ESA hyporesponsiveness and low handgrip strength linked to ~4.2-fold higher death or CVD in hemodialysis.
Why the study?
The combined effect of erythropoietin hyporesponsiveness and low handgrip strength on the prognosis of patients undergoing hemodialysis warranted investigation.
Does the combination of erythropoiesis-stimulating agent hyporesponsiveness and low handgrip strength increase the risk of all-cause mortality and cardiovascular disease in patients undergoing maintenance hemodialysis?
Cohort (n=175)
Yes
Does the combination of erythropoiesis-stimulating agent hyporesponsiveness and low handgrip strength increase the risk of all-cause mortality and cardiovascular disease in patients undergoing maintenance hemodialysis?
Answers are grounded in this paper and cite their sources.
The coexistence of erythropoietin hyporesponsiveness and low handgrip strength synergistically increases the risk of cardiovascular events and all-cause death in patients undergoing maintenance hemodialysis, offering a stronger prognostic marker than either factor alone.
INTRODUCTION: We examined the combined effect of erythropoietin (EPO) hyporesponsiveness and low handgrip strength (HGS) on the prognosis of patients undergoing hemodialysis (HD). METHODS: = 182). Patients of ≥20 years of age and who had been undergoing HD for ≧3 months at enrollment were eligible for inclusion. Seven patients treated with epoetin-β pegol were excluded. First, the erythropoietin resistance index (ERI) and HGS were measured. The patients were stratified by the ERI of 9.44 (U/kg/week/g/dL), and by the HGS of 28 kg for men and 18 kg for women. We then observed death and cardiovascular disease (CVD), composite endpoint (deaths or CVD) for a median of 2 years. RESULTS: = 53; age, 34-92 years) were included in the analysis. During the observation period of 24 months, 57 events (14 deaths and 43 CVD) were observed. High ERI and low HGS were associated with a high incidence of endpoints compared to low ERI and high HGS. Among the four groups classified by ERI and HGS values, the highest risk group was the high ERI/low HGS group (HR: 4.20 95% CI 2.12-8.33). CONCLUSIONS: EPO hyporesponsiveness combined with low HGS were found to be significant predictors of a poor outcome, and the synergistic effects of the two factors had stronger predictive ability than either single factor.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2022) conducted a cohort in End-stage kidney disease undergoing maintenance hemodialysis (n=175). High erythropoietin resistance index (ERI ≥9.44 U/kg/week/g/dL) combined with low handgrip strength (HGS <28 kg in men, <18 kg in women) vs. Low erythropoietin resistance index (<9.44 U/kg/week/g/dL) and high handgrip strength (≥28 kg in men, ≥18 kg in women) was evaluated on Composite of all-cause mortality or cardiovascular disease (angina, myocardial infarction, arteriosclerosis obliterans, cerebral hemorrhage, cerebral infarction, or heart failure) (HR 4.20, 95% CI 2.12-8.33, p=<0.0001). Combined erythropoietin hyporesponsiveness and low handgrip strength quadrupled the risk of all-cause death or cardiovascular disease in hemodialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: